Ping Zhan

5PUBLICATIONS
28CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 19, 2025
Antibody-drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC: a Bayesian network meta-analysis.

Yueying Chen, Yanjun Du, Juan Ni

|Oct 28, 2025
Intrapleural anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer with malignant pleural effusion: a prospective, single-arm, single-center, phase I trial.

Yuting Cui, Qiuxia Wu, Yue Hao

|Oct 22, 2024
First-line chemoimmunotherapy for patients with small-cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis.

Yu Li, Yuxin Jiang, Luyun Pan

|Sep 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Xingxiang Pu, Chunwei Xu, Qian Wang

|Jul 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.

Qian Wang, Chunwei Xu, Wenxian Wang

Pageof 1

Frequent Collaborators

3 joint publications

Hongbing Liu

3 joint publications

Tangfeng Lv

2 joint publications

Chunwei Xu

2 joint publications

Wenxian Wang